Dashboard
Manage Tickers

PFE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mark-cuban-isnt-convinced-trumprx-is-going-to-change-the-game-but-hes-giving-them-credit-for-trying
Mark Cuban Isn't Convinced TrumpRx Is Goin...
10/21/2025 05:38:41

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug cost...

reported-sunday-pfizers-braftovi-plus-mektovi-delivers-476-month-median-overall-survival-in-treatment-nave-braf-v600e-mutant-lung-cancer-setting-new-long-term-benchmark
Reported Sunday, Pfizer's BRAFTOVI Plus ME...
10/20/2025 07:44:05

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients w...

Core News & Articles
Reported Sunday, Pfizer And Astellas Repor...
10/20/2025 07:41:36

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in ...

invo-fertility-stock-is-plunging-after-white-house-announcement
Invo Fertility Stock Is Plunging After Whi...
10/17/2025 18:37:05

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

uk-health-agency-recommends-gsk-backed-viiv-healthcares-apretude-as-injectable-hiv-treatment
UK Health Agency Recommends GSK-Backed Vii...
10/17/2025 16:43:32

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to dail...

novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs
Novo Vs. Lilly Vs. Pfizer: Who Wins If Tru...
10/17/2025 14:19:58

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

reported-earlier-pfizer-ceo-says-us-pharma-industry-needs-to-collaborate-with-china--reuters
Reported Earlier: 'Pfizer CEO says US phar...
10/15/2025 11:43:40

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-us-pharma-industry-needs-collaborate-with-china-202...

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
10/15/2025 11:15:13

pfizer-seeks-expanded-use-approval-for-breast-cancer-drug
Pfizer Seeks Expanded Use Approval For Bre...
10/14/2025 17:37:12

Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy an...

hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential
Hedge Fund Shah Capital Urges Novavax To C...
10/14/2025 17:08:17

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

pfizer-announces-topline-results-from-phase-3-her2climb-05-trial-of-first-line-combination-therapy-with-tyrosine-kinase-inhibitor-tukysa-in-patients-with-her2-mbc
Pfizer Announces Topline Results From Phas...
10/14/2025 10:46:49

Pfizer Inc. (NYSE:PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination t...

Core News & Articles
Arvinas And Pfizer To Highlight New Vepdeg...
10/13/2025 11:08:29

Presentation to include new patient-reported outcomes (PRO) data from the Phase 3 VERITAC-2 clinical trial 

pfizer-to-present-46-infectious-disease-abstracts-at-idweek-2025-congress-highlighting-advancements-in-prevention-and-treatment
Pfizer To Present 46 Infectious Disease Ab...
10/13/2025 10:47:25

Pfizer Inc. (NYSE:PFE, "Pfizer"))) will present data across its infectious disease portfolio at the upcoming IDWeek 202...

Core News & Articles
President Trump Announces Achievement On D...
10/10/2025 21:37:40

https://www.youtube.com/watch?v=XOtOCzut9pM

trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans
Trump Plans AstraZeneca Deal To Cut Drug P...
10/10/2025 18:48:27

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

morgan-stanley-maintains-equal-weight-on-pfizer-lowers-price-target-to-32
Morgan Stanley Maintains Equal-Weight on P...
10/10/2025 17:42:29

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $33 to...

trump-administration-engages-pharmacies-goodrx-for-trumprx-launch
Trump Administration Engages Pharmacies, G...
10/09/2025 19:09:34

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

amgen-to-offer-cholesterol-drug-at-60-discount-as-trump-administrations-call-to-lower-drug-prices
Amgen To Offer Cholesterol Drug At 60% Dis...
10/06/2025 18:27:22

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrict...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/06/2025 17:35:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION